[生物疗法在全身性疾病中的非适应证使用] - Suppr

[Off-label use of biological therapies in systemic diseases].

作者信息

Hachulla E

机构信息

Service de médecine interne, centre de référence des maladies auto-immunes et maladies systémiques rares, sclérodermie systémique, hôpital Claude-Huriez, université de Lille-2, avenue Oscar-Lambret, 59037 Lille cedex, France.

出版信息

Rev Med Interne. 2010 Dec;31 Suppl 3:S307-14. doi: 10.1016/j.revmed.2010.09.015. Epub 2010 Oct 30.

DOI:10.1016/j.revmed.2010.09.015

PMID:21036424

Abstract

摘要

相似文献

[Off-label use of biological therapies in systemic diseases].

Rev Med Interne. 2010 Dec;31 Suppl 3:S307-14. doi: 10.1016/j.revmed.2010.09.015. Epub 2010 Oct 30.

Rituximab and its use in autoimmune bullous disorders.

Dermatol Clin. 2011 Oct;29(4):571-5. doi: 10.1016/j.det.2011.06.023.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010.

Ann Rheum Dis. 2011 Mar;70 Suppl 1:i2-36. doi: 10.1136/ard.2010.146852.

[Biotherapies to treat necrotizing vasculitis].

Rev Med Interne. 2010 Dec;31 Suppl 3:S304-6. doi: 10.1016/j.revmed.2010.10.001. Epub 2010 Nov 4.

Biological therapies in rheumatic diseases.

Clin Ter. 2013;164(5):e413-28. doi: 10.7417/CT.2013.1622.

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.

Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii2-25. doi: 10.1136/ard.2008.100834.

[Monitoring and precautions to take during treatment with a biological immunomodulator].

Rev Med Interne. 2010 Dec;31 Suppl 3:S315-8. doi: 10.1016/j.revmed.2010.09.026. Epub 2010 Oct 30.

Update on rituximab.

Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv55-7. doi: 10.1136/ard.2005.042648.

Tumor necrosis factor inhibitors: following best practice.

Manag Care. 2005 May;14(5 Suppl):17-23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Off-label use of biological therapies in systemic diseases].

作者信息

Hachulla E

机构信息

出版信息

Rev Med Interne. 2010 Dec;31 Suppl 3:S307-14. doi: 10.1016/j.revmed.2010.09.015. Epub 2010 Oct 30.

DOI:10.1016/j.revmed.2010.09.015

PMID:21036424

Abstract

摘要

相似文献

[Off-label use of biological therapies in systemic diseases].

Rev Med Interne. 2010 Dec;31 Suppl 3:S307-14. doi: 10.1016/j.revmed.2010.09.015. Epub 2010 Oct 30.

Rituximab and its use in autoimmune bullous disorders.

Dermatol Clin. 2011 Oct;29(4):571-5. doi: 10.1016/j.det.2011.06.023.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010.

Ann Rheum Dis. 2011 Mar;70 Suppl 1:i2-36. doi: 10.1136/ard.2010.146852.

[Biotherapies to treat necrotizing vasculitis].

Rev Med Interne. 2010 Dec;31 Suppl 3:S304-6. doi: 10.1016/j.revmed.2010.10.001. Epub 2010 Nov 4.

Biological therapies in rheumatic diseases.

Clin Ter. 2013;164(5):e413-28. doi: 10.7417/CT.2013.1622.

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.

Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii2-25. doi: 10.1136/ard.2008.100834.

[Monitoring and precautions to take during treatment with a biological immunomodulator].

Rev Med Interne. 2010 Dec;31 Suppl 3:S315-8. doi: 10.1016/j.revmed.2010.09.026. Epub 2010 Oct 30.

Update on rituximab.

Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv55-7. doi: 10.1136/ard.2005.042648.

Tumor necrosis factor inhibitors: following best practice.

Manag Care. 2005 May;14(5 Suppl):17-23.

[Off-label use of biological therapies in systemic diseases].

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

[Off-label use of biological therapies in systemic diseases].

作者信息

机构信息

出版信息

相似文献